| Therapeutic interventions in sepsis: current and anticipated pharmacological agents P Shukla, GM Rao, G Pandey, S Sharma, N Mittapelly, R Shegokar, ... British journal of pharmacology 171 (22), 5011-5031, 2014 | 94 | 2014 |
| Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies S Sharma, A Verma, BV Teja, P Shukla, PR Mishra European Journal of Pharmaceutical Sciences 69, 51-60, 2015 | 75 | 2015 |
| Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic … PK Gupta, AK Jaiswal, S Asthana, A Verma, V Kumar, P Shukla, ... Pharmaceutical research 32, 1727-1740, 2015 | 66 | 2015 |
| Chapter 8 - Interfacial and colloidal properties of emulsified systems: Pharmaceutical and biological perspective S Sharma, P Shukla, A Misra, PR Mishra Colloid and Interface Science in Pharmaceutical Research and Development …, 2014 | 61 | 2014 |
| Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis P Shukla, P Dwivedi, PK Gupta, PR Mishra Expert opinion on drug delivery 11 (11), 1697-1712, 2014 | 44 | 2014 |
| Preparation, Characterization and Evaluation of Chitosan–Gum Arabic Coacervates as Excipient in Fast Dissolving/Disintegrating Dosage Form R MALVIYA, P SHUKLA, P SRIVASTAVA, ZA KAPLANCIKLI, ... FABAD J. Pharm. Sci 34 (1), 13-23, 2009 | 38 | 2009 |
| Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: An approach by enhanced bioavailability P Dwivedi, R Khatik, P Chaturvedi, K Khandelwal, I Taneja, KSR Raju, ... Colloids and Surfaces B: Biointerfaces 126, 467-475, 2015 | 31 | 2015 |
| Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives P Shukla, G Gupta, D Singodia, R Shukla, AK Verma, P Dwivedi, S Kansal, ... Expert Opinion on Drug Delivery 7 (9), 993-1011, 2010 | 31 | 2010 |
| Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis R Shukla, J Gupta, P Shukla, P Dwivedi, P Tripathi, SM Bhattacharya, ... RSC advances 5 (85), 69047-69056, 2015 | 30 | 2015 |
| Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis PK Gupta, S Asthana, AK Jaiswal, V Kumar, AK Verma, P Shukla, ... Bioconjugate chemistry 25 (6), 1091-1102, 2014 | 30 | 2014 |
| Nanoemulsion based concomitant delivery of curcumin and etoposide: Impact on cross talk between prostate cancer cells and osteoblast during metastasis P Shukla, V Mathur, A Kumar, V Khedgikar, BV Teja, D Chaudhary, ... Journal of biomedical nanotechnology 10 (11), 3381-3391, 2014 | 29 | 2014 |
| Development and Performance Evaluation of Amphotericin B Transfersomes Against Resistant and Sensitive Clinical Isolates of Visceral Leishmaniasis D Singodia, GK Gupta, A Verma, V Singh, P Shukla, P Misra, S Sundar, ... Journal of Biomedical Nanotechnology 6 (3), 293-302, 2010 | 29 | 2010 |
| Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo P Dwivedi, S Kansal, M Sharma, R Shukla, A Verma, P Shukla, P Tripathi, ... Journal of Drug Targeting, 1-14, 2012 | 28 | 2012 |
| Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice P Dwivedi, R Khatik, K Khandelwal, R Srivastava, I Taneja, KSR Raju, ... RSC Advances 4 (110), 64905-64918, 2014 | 25 | 2014 |
| Factors influencing drug release characteristic from hydrophilic polymer matrix tablet A Goyal, P Shukla, AK Srivastava Asian journal of pharmaceutical and clinical research 2 (1), 2009 | 23 | 2009 |
| Development of putrescine anchored nano-crystalsomes bearing doxorubicin and oleanolic acid: deciphering their role in inhibiting metastatic breast cancer RP Shukla, S Urandur, VT Banala, D Marwaha, S Gautam, N Rai, N Singh, ... Biomaterials Science 9 (5), 1779-1794, 2021 | 12 | 2021 |
| Chitosan coated curcumin nanocrystals augment pharmacotherapy via improved pharmacokinetics and interplay of NFκB, Keap1 and Nrf2 expression in Gram negative sepsis P Shukla, AK Verma, J Dewangan, SK Rath, PR Mishra RSC advances 5 (70), 57006-57020, 2015 | 12 | 2015 |
| Cationic Nanoemulsions Bearing Ciprofloxacin Surf-Plexes Enhances Its Therapeutic Efficacy in Conditions of E. coli Induced Peritonitis and Sepsis V Jain, P Shukla, R Pal, PR Mishra Pharmaceutical research 31, 2630-2642, 2014 | 12 | 2014 |
| In-vitro and in-vivo studies on novel chitosan-g-pluronic F-127 copolymer based nanocarrier of amphotericin B for improved antifungal activity V Kumar, PK Gupta, VK Pawar, A Verma, R Khatik, P Tripathi, P Shukla, ... Journal of Biomaterials and Tissue Engineering 4 (3), 210-216, 2014 | 12 | 2014 |
| Moxifloxacin-loaded nanoemulsions having tocopheryl succinate as the integral component improves pharmacokinetics and enhances survival in E. coli-induced complicated intra … P Shukla, AK Verma, P Dwivedi, A Yadav, PK Gupta, SK Rath, PR Mishra Molecular Pharmaceutics 11 (12), 4314-4326, 2014 | 11 | 2014 |
Prabhat Ranjan Mishra PhD, FNAScChief Scientist & Head, CSIR-Central Drug Research Institute, LucknowVerified email at cdri.res.in
